-- 据澳大利亚证券交易所周二提交的文件显示，澳大利亚临床实验室（ASX：ACL）否认了米歇尔·拉布-伊万诺夫（Michelle Raab-Ivanov）在维多利亚州最高法院提起的代表诉讼中的指控，并计划“全力”应诉。 文件称，该诉讼代表的是2022年7月15日之前曾是该公司和/或其子公司Medlab Pathology的客户，且其个人信息在2022年2月Medlab Pathology遭受网络攻击后受到影响的个人。 根据文件，该诉讼旨在根据涉嫌违反澳大利亚消费者法的行为，为受影响的个人寻求损害赔偿。
Related Articles
Asia
Joyvio Food's Loss Narrows 96% in Q1
Joyvio Food's (SHE:300268) attributable loss narrowed 96% to 7.84 million yuan in the first quarter from 180.9 million yuan in the year-ago period, according to a Monday filing by parent company Legend Holdings (HKG:3396) with the Hong Kong bourse.Loss per share at the Chinese agricultural products company came in at 0.0450 yuan compared with 1.0385 yuan in the prior-year period.Revenue declined 71% to 194.3 million yuan from 677.5 million yuan in the year-ago period.
$HKG:3396$SHE:300268
Asia
Shengyi Technology's 2025 Profit Surges 92%, Revenue Up 39%
Shengyi Technology (SHA:600183) posted full-year attributable net profit of 3.33 billion yuan in 2025, up 92% from 1.74 billion yuan in 2024.Earnings per share rose to 1.38 yuan from 0.73 yuan, according to a filing with the Shanghai bourse over the weekend.The electronic components manufacturer's revenue climbed 39% year over year to 28.4 billion yuan from 20.4 billion yuan.
$SHA:600183
Asia
East Money Information's Q1 Profit Up 38%, Revenue Rises 44%
East Money Information (SHE:300059) posted first-quarter attributable net profit of 3.74 billion yuan, up 38% from 2.72 billion yuan the previous year.Earnings per share rose to 0.2364 yuan from 0.1719 yuan, according to a filing with the Shenzhen bourse over the weekend.The financial services provider's operating revenue climbed 44% year over year to 5.03 billion yuan from 3.49 billion yuan.
$SHE:300059